Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status
- 16 March 2006
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 99 (3) , 309-311
- https://doi.org/10.1007/s10549-006-9196-x
Abstract
We examined the association of dietary lignan intake with estrogen receptor negative (ER−) and ER positive (ER+) breast cancer risk in a breast cancer case–control study. Among premenopausal women only, there was a reduced risk of ER− breast cancer for those in the highest compared to the lowest quartile of lignan intake suggesting that the observed negative association of lignans with breast cancer may be limited to ER− tumors.Keywords
This publication has 12 references indexed in Scilit:
- The inhibitory effect of flaxseed on the growth and metastasisof estrogen receptor negative human breast cancer xenograftsis attributed to both its lignan and oil componentsInternational Journal of Cancer, 2005
- Effect of Dietary Intake of Phytoestrogens on Estrogen Receptor Status in Premenopausal Women With Breast CancerNutrition and Cancer, 2005
- Dietary lignan intakes and risk of pre- and postmenopausal breast cancerInternational Journal of Cancer, 2004
- Dietary phytoestrogens and healthPhytochemistry, 2004
- Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case‐control studyInternational Journal of Cancer, 2004
- Phytoestrogens and Breast Cancer RiskBreast Cancer Research and Treatment, 2003
- The Risk of Breast Cancer Associated with Dietary Lignans Differs by CYP17 Genotype in WomenJournal of Nutrition, 2002
- Intake of Dietary Phytoestrogens Is Low in Postmenopausal Women in the United States: The Framingham StudyJournal of Nutrition, 2001
- Case-control study of phyto-oestrogens and breast cancerThe Lancet, 1997
- A DATA-BASED APPROACH TO DIET QUESTIONNAIRE DESIGN AND TESTINGAmerican Journal of Epidemiology, 1986